Credit Suisse’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$972K Buy
51,918
+508
+1% +$10.2K ﹤0.01% 2286
2023
Q4
$1.16M Sell
51,410
-3,432
-6% -$74.4K ﹤0.01% 2241
2023
Q3
$1.36M Sell
54,842
-1,646
-3% -$41.4K ﹤0.01% 2082
2023
Q2
$1.59M Buy
56,488
+8,740
+18% +$217K ﹤0.01% 2083
2023
Q1
$1.07M Buy
47,748
+2,925
+7% +$76.6K ﹤0.01% 2290
2022
Q4
$1.19M Buy
44,823
+12,222
+37% +$399K ﹤0.01% 2227
2022
Q3
$926K Buy
32,601
+4,493
+16% +$116K ﹤0.01% 2384
2022
Q2
$586K Buy
28,108
+1,366
+5% +$25.6K ﹤0.01% 2743
2022
Q1
$580K Buy
26,742
+1,279
+5% +$27.8K ﹤0.01% 2891
2021
Q4
$707K Buy
+25,463
New +$617K ﹤0.01% 3579
2021
Q1
Sell
-15,060
Closed -$133K 4315
2020
Q4
$133K Buy
+15,060
New +$123K ﹤0.01% 4152
2020
Q2
Sell
-32,512
Closed -$219K 3970
2020
Q1
$219K Buy
32,512
+8,709
+37% +$82.5K ﹤0.01% 3599
2019
Q4
$277K Sell
23,803
-6,314
-21% -$71.3K ﹤0.01% 3850
2019
Q3
$311K Buy
30,117
+6,774
+29% +$66.6K ﹤0.01% 3676
2019
Q2
$219K Sell
23,343
-7,950
-25% -$61.2K ﹤0.01% 3816
2019
Q1
$221K Buy
31,293
+1,015
+3% +$8.7K ﹤0.01% 3731
2018
Q4
$223K Buy
30,278
+511
+2% +$4.28K ﹤0.01% 3633
2018
Q3
$260K Sell
29,767
-10,891
-27% -$111K ﹤0.01% 3579
2018
Q2
$458K Buy
40,658
+2,173
+6% +$25.9K ﹤0.01% 3468
2018
Q1
$428K Buy
38,485
+1,466
+4% +$18.4K ﹤0.01% 3432
2017
Q4
$473K Sell
37,019
-14,845
-29% -$196K ﹤0.01% 3460
2017
Q3
$738K Buy
51,864
+25,473
+97% +$319K ﹤0.01% 3297
2017
Q2
$340K Sell
26,391
-6,061
-19% -$78.1K ﹤0.01% 3388
2017
Q1
$466K Sell
32,452
-10,319
-24% -$152K ﹤0.01% 3333
2016
Q4
$668K Buy
42,771
+15,851
+59% +$217K ﹤0.01% 3292
2016
Q3
$317K Sell
26,920
-708
-3% -$9.32K ﹤0.01% 3634
2016
Q2
$384K Sell
27,628
-8,570
-24% -$114K ﹤0.01% 3567
2016
Q1
$421K Sell
36,198
-556
-2% -$7.07K ﹤0.01% 3343
2015
Q4
$603K Buy
36,754
+23,030
+168% +$366K ﹤0.01% 3222
2015
Q3
$187K Sell
13,724
-12,110
-47% -$164K ﹤0.01% 3946
2015
Q2
$327K Sell
25,834
-1,005
-4% -$11.4K ﹤0.01% 3979
2015
Q1
$318K Buy
26,839
+9,047
+51% +$104K ﹤0.01% 3829
2014
Q4
$222K Buy
17,792
+6,329
+55% +$64.6K ﹤0.01% 4220
2014
Q3
$106K Sell
11,463
-12,008
-51% -$92.1K ﹤0.01% 4287
2014
Q2
$153K Sell
23,471
-81,104
-78% -$536K ﹤0.01% 4450
2014
Q1
$844K Buy
104,575
+24,070
+30% +$237K ﹤0.01% 3268
2013
Q4
$803K Buy
80,505
+58,851
+272% +$408K ﹤0.01% 3456
2013
Q3
$131K Buy
21,654
+6,635
+44% +$38K ﹤0.01% 4067
2013
Q2
$77K Buy
+15,019
New +$77K ﹤0.01% 4062

Other funds holding CCRN

Credit Suisse's CCRN Position: Q1 2024 in Review

Credit Suisse increased its Cross Country Healthcare (CCRN) stake by 0.99% in Q1 2024, buying an estimated $10.2K and bringing the position to 51,918 shares worth $972K. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

Credit Suisse first reported a position in CCRN in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.59M in Q2 2023. 175 funds tracked by Wall St. Rank hold CCRN as of Q1 2024.

  • Credit Suisse held 51,918 shares of Cross Country Healthcare worth $972K as of Q1 2024.
  • Credit Suisse bought 508 Cross Country Healthcare shares in Q1 2024, an estimated $10.2K.
  • Cross Country Healthcare made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2286 holding.
  • Credit Suisse first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 39 quarters since.
  • Credit Suisse's Cross Country Healthcare position peaked at $1.59M in Q2 2023.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.